このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Edwards Lifesciences マネジメント
マネジメント 基準チェック /34
Edwards Lifesciences'の CEO はBernard Zovighianで、 May2023年に任命され、 の在任期間は 1.08年です。 の年間総報酬は$ 12.87Mで、 7.6%給与と92.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.012%を直接所有しており、その価値は$ 6.22M 。経営陣と取締役会の平均在任期間はそれぞれ5年と6年です。
主要情報
Bernard Zovighian
最高経営責任者
US$12.9m
報酬総額
| CEO給与比率 | 7.6% |
| CEO在任期間 | 1.1yrs |
| CEOの所有権 | 0.01% |
| 経営陣の平均在職期間 | 5yrs |
| 取締役会の平均在任期間 | 6yrs |
経営陣の近況
Recent updates
Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13
Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?
Mar 22Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)
Mar 10Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Feb 26Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges
Feb 06Edwards Lifesciences slips as Piper downgrades on challenging setup
Jan 30Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity
Jan 18Edwards Lifesciences: Catalysts For 2023 And Beyond
Dec 30Is Edwards Lifesciences (NYSE:EW) A Risky Investment?
Dec 28Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Dec 16CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$13m | US$973k | US$1b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$3m | US$642k | US$2b |
報酬と市場: Bernardの 総報酬 ($USD 12.87M ) は、 US市場 ($USD 13.55M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Bernardの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。
CEO（最高経営責任者
Bernard Zovighian (56 yo)
1.1yrs
在職期間
US$12,869,020
報酬
Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$12.87m | 0.012% $ 6.3m | |
| Corporate VP & CFO | 10.4yrs | US$5.95m | 0.045% $ 24.0m | |
| Corporate Vice President of Strategy & Corporate Development | 8.3yrs | US$4.29m | 0.034% $ 18.1m | |
| Corporate VP and Group President of TAVR & Surgical Structural Heart | 1.4yrs | US$5.40m | 0.034% $ 17.9m | |
| Corporate VP of Advanced Technology & Chief Scientific Officer | 5.3yrs | データなし | データなし | |
| Vice President of Investor Relations | no data | データなし | データなし | |
| Corporate VP & General Counsel | 4.8yrs | データなし | データなし | |
| Corporate Vice President of Public Affairs | 11yrs | データなし | データなし | |
| Corporate Vice President of Human Resources | 11.8yrs | データなし | データなし | |
| Senior Vice President of Quality & Regulatory Compliance | less than a year | データなし | データなし | |
| GM & Senior VP of Surgical Structural Heart | less than a year | データなし | データなし | |
| VP & Corporate Controller | no data | データなし | 0.0051% $ 2.7m |
5.0yrs
平均在職期間
58.5yo
平均年齢
経験豊富な経営陣: EWの経営陣は経験豊富で経験豊富です（平均在職期間は5年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$12.87m | 0.012% $ 6.3m | |
| Independent Director | 9.3yrs | US$335.06k | 0.012% $ 6.3m | |
| Independent Director | 3.9yrs | US$329.97k | 0.0013% $ 676.2k | |
| Independent Director | 8.3yrs | US$335.06k | 0.012% $ 6.3m | |
| Independent Director | 7.9yrs | US$356.42k | 0.0045% $ 2.4m | |
| Independent Chairman | 9.6yrs | US$347.97k | 0.011% $ 6.0m | |
| Independent Director | less than a year | データなし | データなし | |
| Independent Director | 4.1yrs | US$334.97k | 0.0018% $ 966.8k |
6.0yrs
平均在職期間
64.5yo
平均年齢
経験豊富なボード: EWの 取締役会 は 経験豊富 であると考えられます ( 6年の平均在任期間)。